A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)
Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude
|3||Active, not recruiting||
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
† Study has passed its completion date and status has not been verified in more than two years.